Endothelial IL-33 Expression Is Augmented by Adenoviral Activation of the DNA Damage Machinery
Author(s) -
Tor Espen Stav-Noraas,
Reidunn J. Edelmann,
Lars la Cour Poulsen,
Olav Sundnes,
Danh Phung,
Axel M. Küchler,
Fredrik Müller,
Amine Kamen,
Guttorm Haraldsen,
Mari Kaarbø,
Johanna Hol Fosse
Publication year - 2017
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.1600054
Subject(s) - transduction (biophysics) , dna damage , microbiology and biotechnology , irf1 , signal transduction , biology , regulator , endothelial stem cell , dna , cytotoxic t cell , gene expression , gene , in vitro , biochemistry
IL-33, required for viral clearance by cytotoxic T cells, is generally expressed in vascular endothelial cells in healthy human tissues. We discovered that endothelial IL-33 expression was stimulated as a response to adenoviral transduction. This response was dependent on MRE11, a sensor of DNA damage that can also be activated by adenoviral DNA, and on IRF1, a transcriptional regulator of cellular responses to viral invasion and DNA damage. Accordingly, we observed that endothelial cells responded to adenoviral DNA by phosphorylation of ATM and CHK2 and that depletion or inhibition of MRE11, but not depletion of ATM, abrogated IL-33 stimulation. In conclusion, we show that adenoviral transduction stimulates IL-33 expression in endothelial cells in a manner that is dependent on the DNA-binding protein MRE11 and the antiviral factor IRF1 but not on downstream DNA damage response signaling.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom